Letter: should we delay surgery, or stop anti‐TNF therapy prior to elective surgical procedures in Crohn’s disease patients receiving anti‐TNF agents? Authors’ reply

• Published in: Alimentary pharmacology & therapeutics Vol. 50; no. 8; pp. 970 - 971
• Main Authors: Lin, Yang‐Sheng, Chen, Ming‐Jen, Lin, Wei‐Chen, Wang, Yuan‐Hung, Chen, Chiehfeng
• Format: Journal Article
• Language: English
• Published: England Wiley Subscription Services, Inc 01.10.2019
• Subjects: Adalimumab; Crohn Disease - surgery; Elective Surgical Procedures; Humans; Infliximab; Surgery; Tumor Necrosis Factor-alpha

LINKED CONTENTThis article is linked to Line et al and Yamamoto and Kotze papers. To view these articles, visit https://doi.org/10.1111/apt.15184 and https://doi.org/10.1111/apt.15450.